US stock futures hovered around the flatline as Wall Street awaited another pulse check on inflation after Tuesday's tepid ...

Key Points GAAP earnings per share of $0.04 exceeded the consensus estimate of negative $0.08 for Q2 2025 No commercial revenue reported; company remains in pre-revenue phase with product launches ...

Much of the recent success of crypto has been driven largely by increasing adoption among institutional investors. Unlike its ...

U.S. stocks are ticking higher after a rally spurred by hopes for lower U.S. interest rates wrapped around the world. The S&P 500 rose 0.2% Wednesday, coming off its latest all-time high. The Dow ...

Key Points Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year ...

The S&P/ASX 200 is set to recoup some of yesterday's losses thanks to a strong overnight session. Plus, a massive day for ASX ...

The benchmark S&P 500 and Nasdaq indices hit new closing highs for the second straight day on Wednesday on hopes that the ...

Key Points Jasper Therapeutics (NASDAQ:JSPR) reported a GAAP loss per share of $1.74 for Q2 2025. Research and development expenses (GAAP) nearly doubled to $21.2 million in Q2 2025 from $11.3 million ...

U.S. stocks are drifting around their record levels after a rally spurred by hopes for lower U.S. interest rates wrapped around the world. The S&P 500 rose 0.1% Wednesday, coming off its latest ...